News

South San Francisco, CA, May 29, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded $4.7 million to ...
The Strategic Allocation Framework (SAF) reflects a refined vision to ensure that CIRM’s investments are aligned with its mission.
The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...
极低频低强度电磁场 (ELF-EMF) 疗法是一种非侵入性脑刺激方法,可以调节神经保护和神经可塑性。最近的一项小规模试点临床试验 (NCT04039178) 表明,ELF-EMF 可以促进人类中风的恢复。ELF-EMF 的频率 ...
Shared Labs Grant – Establishing SRLs Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center Stem cell-based Parternship Resource for Investigating Human Diseases and Training ...
We are deeply saddened to learn of the passing of a subject enrolled in Rocket Pharmaceuticals’ Phase 2 clinical trial of RP-A501 to treat Danon disease. On behalf of the California Institute for ...
除红细胞外,哺乳动物细胞都含有线粒体。线粒体是一种细胞器,负责提供能量、中间代谢产物以及其他维持细胞活力、复制和功能的活性。线粒体含有多个拷贝的环状基因组,称为线粒体DNA ...
Late Stage Preclinical Projects Aaron Nagiel Development of a novel intravitreal AAV gene therapy for the rare disease blue cone monochromacy. $4,691,936 Get the latest CIRM news, information on ...
Severe Combined Immunodeficiency (SCID) is a rare primary immunodeficiency in which patients lack T and B cells, the white blood cells needed to fight infections. Without a bone marrow stem cell ...
Recevez les dernières nouvelles du CIRM, des informations sur les réunions à venir et les opportunités de financement dans votre boîte de réception.
从多能干细胞 (PSC) 中生成嵌合抗原受体 (CAR) T 细胞将推动癌症免疫疗法的发展。了解 CAR 如何影响 T 细胞从 PSC 分化对于这项工作至关重要。最近描述的人工胸腺类器官 (ATO) 系统支持 PSC 体外 ...
The use of stem cell technology to study neurodegenerative diseases has been a burgeoning area of research in recent years. Recent work by us and others have demonstrated that stem cell derived ...